Novartis Global Health Head Touts Commitment to Fight Diseases in ‘Market Failures’ at HBS Talk

Lutz Hegemann, the head of global health at Swiss pharmaceutical manufacturer Novartis, said the company will continue to invest in drugs to fight diseases without strong profit incentives and maintain regional commitments in Sub-Saharan Africa at a Harvard Business School talk on Friday.